• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常规临床实践中冠状动脉事件后不良风险因素的控制。

Unfavourable risk factor control after coronary events in routine clinical practice.

作者信息

Sverre Elise, Peersen Kari, Husebye Einar, Gjertsen Erik, Gullestad Lars, Moum Torbjørn, Otterstad Jan Erik, Dammen Toril, Munkhaugen John

机构信息

Department of Medicine, Drammen Hospital, 3004, Drammen, Norway.

Department of Medicine, Vestfold Hospital, Tonsberg, Norway.

出版信息

BMC Cardiovasc Disord. 2017 Jan 21;17(1):40. doi: 10.1186/s12872-016-0387-z.

DOI:10.1186/s12872-016-0387-z
PMID:28109259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5251244/
Abstract

BACKGROUND

Risk factor control after a coronary event in a recent European multi-centre study was inadequate. Patient selection from academic centres and low participation rate, however, may underscore failing risk factor control in routine clinical practice. Improved understanding of the patient factors that influence risk factor control is needed to improve secondary preventive strategies. The objective of the present paper was to determine control of the major risk factors in a coronary population from routine clinical practice, and how risk factor control was influenced by the study factors age, gender, number of coronary events, and time since the index event.

METHODS

A cross-sectional study determined risk factor control and its association with study factors in 1127 patients (83% participated) aged 18-80 years with acute myocardial infarction and/or revascularization identified from medical records. Study data were collected from a self-report questionnaire, clinical examination, and blood samples after 2-36 months (median 16) follow-up.

RESULTS

Twenty-one percent were current smokers at follow-up. Of those smoking at the index event 56% continued smoking. Obesity was found in 34%, and 60% were physically inactive. Although 93% were taking blood-pressure lowering agents and statins, 46% were still hypertensive and 57% had LDL cholesterol >1.8 mmol/L at follow-up. Suboptimal control of diabetes was found in 59%. The patients failed on average to control three of the six major risk factors, and patients with >1 coronary events (p < 0.001) showed the poorest overall control. A linear increase in smoking (p < 0.01) and obesity (p < 0.05) with increasing time since the event was observed.

CONCLUSIONS

The majority of coronary patients in a representative Norwegian population did not achieve risk factor control, and the poorest overall control was found in patients with several coronary events. New strategies for secondary prevention are clearly needed to improve risk factor control. Even modest advances will provide major health benefits.

TRIAL REGISTRATION

Registered at ClinicalTrials.gov (ID NCT02309255 ).

摘要

背景

在最近一项欧洲多中心研究中,冠状动脉事件后的危险因素控制情况并不理想。然而,从学术中心选择患者以及参与率较低,可能突出了常规临床实践中危险因素控制的失败。为了改进二级预防策略,需要更好地了解影响危险因素控制的患者因素。本文的目的是确定常规临床实践中冠状动脉疾病患者主要危险因素的控制情况,以及研究因素年龄、性别、冠状动脉事件数量和距索引事件的时间对危险因素控制的影响。

方法

一项横断面研究确定了1127名年龄在18 - 80岁、患有急性心肌梗死和/或血管重建的患者(参与率83%)的危险因素控制情况及其与研究因素的关联,这些患者是从医疗记录中识别出来的。研究数据通过自我报告问卷、临床检查以及在2 - 36个月(中位数16个月)随访后的血样收集。

结果

随访时21%的患者为当前吸烟者。在索引事件时吸烟的患者中,56%继续吸烟。34%的患者存在肥胖,60%的患者身体活动不足。尽管93%的患者正在服用降压药和他汀类药物,但随访时仍有46%的患者患有高血压,57%的患者低密度脂蛋白胆固醇>1.8 mmol/L。59%的患者糖尿病控制不佳。患者平均未能控制六个主要危险因素中的三个,发生>1次冠状动脉事件的患者总体控制最差(p < 0.001)。观察到随着事件发生时间的增加,吸烟(p < 0.01)和肥胖(p < 0.05)呈线性增加。

结论

在具有代表性的挪威人群中,大多数冠状动脉疾病患者未能实现危险因素控制,发生多次冠状动脉事件的患者总体控制最差。显然需要新的二级预防策略来改善危险因素控制。即使是适度的进展也将带来重大的健康益处。

试验注册

在ClinicalTrials.gov注册(ID NCT02309255)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922c/5251244/26ae0d5593a5/12872_2016_387_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922c/5251244/7a75bbe033ef/12872_2016_387_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922c/5251244/26ae0d5593a5/12872_2016_387_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922c/5251244/7a75bbe033ef/12872_2016_387_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/922c/5251244/26ae0d5593a5/12872_2016_387_Fig2_HTML.jpg

相似文献

1
Unfavourable risk factor control after coronary events in routine clinical practice.常规临床实践中冠状动脉事件后不良风险因素的控制。
BMC Cardiovasc Disord. 2017 Jan 21;17(1):40. doi: 10.1186/s12872-016-0387-z.
2
Medical and sociodemographic factors predict persistent smoking after coronary events.医学和社会人口学因素可预测冠心病事件后的持续吸烟情况。
BMC Cardiovasc Disord. 2017 Sep 6;17(1):241. doi: 10.1186/s12872-017-0676-1.
3
Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population.可预防的临床和心理社会因素可预测冠状动脉人群中三分之二的复发性心血管事件中的两起。
BMC Cardiovasc Disord. 2020 Feb 5;20(1):61. doi: 10.1186/s12872-020-01368-6.
4
Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.冠心病事件后糖尿病前期和2型糖尿病患者的管理:需要个体化定制——一项横断面研究
BMC Cardiovasc Disord. 2018 Aug 3;18(1):160. doi: 10.1186/s12872-018-0896-z.
5
The role of cardiac rehabilitation in secondary prevention after coronary events.心脏康复在冠心病事件二级预防中的作用。
Eur J Prev Cardiol. 2017 Sep;24(13):1360-1368. doi: 10.1177/2047487317719355. Epub 2017 Jun 30.
6
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.欧洲动脉粥样硬化调查项目IV:欧洲心脏病学会对来自24个欧洲国家的冠心病患者的生活方式、危险因素及治疗管理情况的调查。
Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16.
7
Long-term secondary prevention of acute myocardial infarction (SEPAT) - guidelines adherence and outcome.急性心肌梗死的长期二级预防(SEPAT)——指南依从性与结局
BMC Cardiovasc Disord. 2016 Nov 17;16(1):226. doi: 10.1186/s12872-016-0400-6.
8
Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.冠心病患者的医学和社会心理因素与低密度脂蛋白胆固醇控制不佳
Eur J Prev Cardiol. 2017 Jun;24(9):981-989. doi: 10.1177/2047487317693134. Epub 2017 Feb 14.
9
The prevalence and predictors of elevated C-reactive protein after a coronary heart disease event.冠心病事件后 C-反应蛋白升高的患病率及其预测因素。
Eur J Prev Cardiol. 2018 Jun;25(9):923-931. doi: 10.1177/2047487318768940. Epub 2018 Apr 11.
10
[Profile of risk factors modification after coronary revascularization in patients with coronary artery disease].[冠心病患者冠状动脉血运重建术后危险因素修正情况]
Zhonghua Yi Xue Za Zhi. 2006 Apr 25;86(16):1097-101.

引用本文的文献

1
Follow-Up in Primary Care After Ischemic Stroke - Insights From the Nor-COAST Study.缺血性中风后初级保健中的随访——来自挪威海岸研究的见解。
Int J Gen Med. 2025 Apr 15;18:2141-2150. doi: 10.2147/IJGM.S508154. eCollection 2025.
2
Smoking cessation and prognosis during long-term follow-up after stroke, TIA, and acute coronary syndrome-results from the randomized controlled NAILED trial.戒烟与卒中和 TIA 及急性冠脉综合征长期随访期间的预后-NAILED 随机对照试验的结果。
PLoS One. 2024 Nov 11;19(11):e0311955. doi: 10.1371/journal.pone.0311955. eCollection 2024.
3
The CNIC-polypill (acetylsalicylic acid, atorvastatin, and ramipril), an effective and cost-saving secondary prevention strategy compared with other therapeutic options in patients with ischaemic heart disease.

本文引用的文献

1
The role of medical and psychosocial factors for unfavourable coronary risk factor control.医学和社会心理因素在不良冠状动脉危险因素控制中的作用。
Scand Cardiovasc J. 2016;50(1):1-8. doi: 10.3109/14017431.2015.1111408. Epub 2015 Nov 17.
2
Cardiovascular disease in Europe--epidemiological update 2015.欧洲心血管病状况—2015 年流行病学更新
Eur Heart J. 2015 Oct 21;36(40):2696-705. doi: 10.1093/eurheartj/ehv428. Epub 2015 Aug 25.
3
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries.
与缺血性心脏病患者的其他治疗选择相比,CNIC复方制剂(阿司匹林、阿托伐他汀和雷米普利)是一种有效且节省成本的二级预防策略。
Eur Heart J Open. 2024 Apr 2;4(2):oeae027. doi: 10.1093/ehjopen/oeae027. eCollection 2024 Mar.
4
Association between salt sensitivity and blood pressure variability in patients with essential hypertension and predictive value for cardiovascular events.原发性高血压患者的盐敏感性与血压变异性的关系及其对心血管事件的预测价值。
Cardiovasc J Afr. 2023;34(4):225-230. doi: 10.5830/CVJA-2022-048. Epub 2023 Mar 22.
5
Nurses' perspectives on the barriers to and facilitators of the implementation of secondary prevention for people with coronary heart disease: a qualitative descriptive study.护士对实施冠心病二级预防障碍和促进因素的看法:定性描述性研究。
BMJ Open. 2022 Sep 26;12(9):e063029. doi: 10.1136/bmjopen-2022-063029.
6
Chronic remote ischemic conditioning for symptomatic internal carotid or middle cerebral artery occlusion: A prospective cohort study.慢性远程缺血预处理治疗症状性颈内或大脑中动脉闭塞:一项前瞻性队列研究。
CNS Neurosci Ther. 2022 Sep;28(9):1365-1371. doi: 10.1111/cns.13874. Epub 2022 Jun 15.
7
Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial.长期基于医院的冠心病二级预防:一项随机对照试验。
BMC Cardiovasc Disord. 2021 Dec 16;21(1):600. doi: 10.1186/s12872-021-02426-3.
8
High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?高密度脂蛋白亚组分:无事生非还是具有临床重要性?
Biomedicines. 2021 Jul 18;9(7):836. doi: 10.3390/biomedicines9070836.
9
Prognostic impact of non-improvement of global longitudinal strain in patients with revascularized acute myocardial infarction.经血运重建的急性心肌梗死患者的整体纵向应变无改善的预后影响。
Int J Cardiovasc Imaging. 2021 Dec;37(12):3477-3487. doi: 10.1007/s10554-021-02349-2. Epub 2021 Jul 29.
10
Adherence to prescription guidelines and achievement of treatment goals among persons with coronary heart disease in Tromsø 7.特罗姆瑟 7 号人群中冠心病患者对处方指南的遵守情况和治疗目标的实现情况。
BMC Cardiovasc Disord. 2021 Jan 21;21(1):44. doi: 10.1186/s12872-021-01866-1.
欧洲动脉粥样硬化调查项目IV:欧洲心脏病学会对来自24个欧洲国家的冠心病患者的生活方式、危险因素及治疗管理情况的调查。
Eur J Prev Cardiol. 2016 Apr;23(6):636-48. doi: 10.1177/2047487315569401. Epub 2015 Feb 16.
4
(2) Classification and diagnosis of diabetes.(2) 糖尿病的分类与诊断。
Diabetes Care. 2015 Jan;38 Suppl:S8-S16. doi: 10.2337/dc15-S005.
5
Secondary prevention after acute myocardial infarction: drug adherence, treatment goals, and predictors of health lifestyle habits. The BLITZ-4 Registry.急性心肌梗死后的二级预防:药物依从性、治疗目标及健康生活方式习惯的预测因素。BLITZ - 4注册研究
Eur J Prev Cardiol. 2015 Dec;22(12):1548-56. doi: 10.1177/2047487314561876. Epub 2014 Dec 1.
6
Non-adherence to cardiovascular medications.心血管药物治疗不依从。
Eur Heart J. 2014 Dec 7;35(46):3267-76. doi: 10.1093/eurheartj/ehu364. Epub 2014 Sep 28.
7
Geographical variations in the prevalence and management of cardiovascular risk factors in outpatients with CAD: Data from the contemporary CLARIFY registry.冠心病门诊患者心血管危险因素患病率及管理的地域差异:来自当代CLARIFY注册研究的数据。
Eur J Prev Cardiol. 2015 Aug;22(8):1056-65. doi: 10.1177/2047487314547652. Epub 2014 Aug 21.
8
Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology.心脏康复中的社会心理因素:从理论到实践。欧洲心脏病学会心血管预防与康复协会心脏康复分会的立场文件。
Eur J Prev Cardiol. 2015 Oct;22(10):1290-306. doi: 10.1177/2047487314543075. Epub 2014 Jul 24.
9
Trends in acute myocardial infarction event rates and risk of recurrences after an incident event in Norway 1994 to 2009 (from a Cardiovascular Disease in Norway Project).挪威 1994 至 2009 年急性心肌梗死事件发生率和再发风险的趋势(源自挪威心血管疾病项目)
Am J Cardiol. 2014 Jun 1;113(11):1777-81. doi: 10.1016/j.amjcard.2014.03.006. Epub 2014 Mar 15.
10
Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with percutaneous coronary intervention: systematic review and meta-analysis.急性冠状动脉综合征后超过12个月停用双联抗血小板治疗会增加接受经皮冠状动脉介入治疗患者发生不良事件的风险:系统评价和荟萃分析。
J Interv Cardiol. 2014 Jun;27(3):233-41. doi: 10.1111/joic.12107. Epub 2014 Mar 14.